{"id":"fepradinol","rwe":[],"tags":[{"label":"fepradinol","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"Active","category":"status"},{"label":"Analgesics","category":"pharmacology"},{"label":"Analgesics, Non-Narcotic","category":"pharmacology"},{"label":"Anti-Inflammatory Agents","category":"pharmacology"},{"label":"Anti-Inflammatory Agents, Non-Steroidal","category":"pharmacology"},{"label":"Antirheumatic Agents","category":"pharmacology"},{"label":"Peripheral Nervous System Agents","category":"pharmacology"},{"label":"Sensory System Agents","category":"pharmacology"}],"phase":"phase_2","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":["fepradinol hydrochloride","fepradinol"],"offLabel":[],"synonyms":["fepradinol hydrochloride","fepradinol"],"timeline":[],"approvals":[],"ecosystem":[],"mechanism":{"modality":"Small Molecule","drugClass":"fepradinol","explanation":"Imagine your body's cells have locks on them, and FEPRADINOL is a key that fits into those locks. When it binds to the locks, it can either block or enhance the activity of the cells, depending on the specific target. This can help to treat various conditions by modulating the activity of the cells.","oneSentence":"FEPRADINOL is thought to work by interacting with specific biological targets to produce its therapeutic effects.","technicalDetail":"FEPRADINOL is a non-steroidal anti-inflammatory agent that may exert its effects through the inhibition of prostaglandin synthesis or other mechanisms, but the exact details of its pharmacology are not well understood."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/1168","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=FEPRADINOL","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T11:30:09.485280","biosimilars":[],"competitors":[],"genericName":"fepradinol","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"UNII":"860MHI4WBA","CHEBI":"CHEBI:134878","INN_ID":"5456","UMLSCUI":"C0211039","ChEMBL_ID":"CHEMBL2106269","KEGG_DRUG":"D07954","DRUGBANK_ID":"DB15902","PUBCHEM_CID":"68819","SNOMEDCT_US":"717097006","SECONDARY_CAS_RN":"67704-50-1","MESH_SUPPLEMENTAL_RECORD_UI":"C078462"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":14,"therapeuticAreas":["Other"],"biosimilarFilings":[],"recentPublications":[],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","brandName":"FEPRADINOL","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"","aiSummary":"FEPRADINOL is a small molecule. Its exact function and indications are not specified in the provided information.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":false,"score":1}}